Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
Somaserve secures IP and global commercial rights to the ‘bionic nanoparticle’ technology PolyNaut®
Somaserve Ltd, a newly founded UCLB spinout company from the UCL department of Chemistry, today announced that it has secured the IP and global commercial rights to the PolyNaut®technology, also known as ‘the bionic nanoparticle’.
Novel method of analysis of stroke data
How does Portico Ventures support non-patentable and fast-to-deploy technologies?
As Portico Ventures is well under way at UCL, we catch up with Programme Manager Denisa Naidin on how UCLB’s work is helping to speed up the route to commercialisation for Computer Science innovations at UCL.